Hybridization into a Bitopic Ligand Increased Muscarinic Receptor Activation for Isopilocarpine but Not for Pilocarpine Derivatives

Journal of Natural Products
2023.0

Abstract

Pilocarpine (1), a secondary metabolite of several Pilocarpus species, is a therapeutically used partial agonist of muscarinic acetylcholine receptors (mAChRs). The available pharmacological data and structure-activity relationships do not provide comparable data for all five receptor subtypes. In this study, pilocarpine (1), its epimer isopilocarpine (2), racemic analogues pilosinine (3) and desmethyl pilosinine (4), and the respective hybrid ligands with a naphmethonium fragment (5-C6 to 8-C6) were synthesized and analyzed in mini-G nano-BRET assays at the five mAChRs. In line with earlier studies, pilocarpine was the most active compound among the orthosteric ligands 1-4. Computational docking of pilocarpine and isopilocarpine to the active M(2) receptor suggests that the trans-configuration of isopilocarpine leads to a loss of the hydrogen bond from the lactone carbonyl to N(6.52), explaining the lower activity of isopilocarpine. Hybrid formation of pilocarpine (1) and isopilocarpine (2) led to an inverted activity rank, with the trans-configured isopilocarpine hybrid (6-C6) being more active. The hydrogen bond of interest is formed by the isopilocarpine hybrid (6-C6) but not by the pilocarpine hybrid (5-C6). Hybridization thus leads to a modified binding mode of the orthosteric moiety, as the binding mode of the hybrid is dominated by the high-affinity allosteric moiety.

Knowledge Graph

Similar Paper

Hybridization into a Bitopic Ligand Increased Muscarinic Receptor Activation for Isopilocarpine but Not for Pilocarpine Derivatives
Journal of Natural Products 2023.0
Muscarinic activity of the thiolactone, lactam, lactol, and thiolactol analogs of pilocarpine and a hypothetical model for the binding of agonists to the M1 receptor
Journal of Medicinal Chemistry 1992.0
Hybrid Molecules from Xanomeline and Tacrine: Enhanced Tacrine Actions on Cholinesterases and Muscarinic M<sub>1</sub>Receptors
Journal of Medicinal Chemistry 2010.0
Cyclic carbamate analogs of pilocarpine
Journal of Medicinal Chemistry 1989.0
Quaternary pilocarpine derivatives as potential acetylcholine antagonists. 2. Alterations in the lactone and imidazole moieties
Journal of Medicinal Chemistry 1976.0
Probing the Pharmacophore for Allosteric Ligands of Muscarinic M<sub>2</sub>Receptors:  SAR and QSAR Studies in a Series of Bisquaternary Salts of Caracurine V and Related Ring Systems
Journal of Medicinal Chemistry 2004.0
First Gallamine−Tacrine Hybrid:  Design and Characterization at Cholinesterases and the M<sub>2</sub> Muscarinic Receptor
Journal of Medicinal Chemistry 2007.0
Discovery of Selective M4 Muscarinic Acetylcholine Receptor Agonists with Novel Carbamate Isosteres
ACS Medicinal Chemistry Letters 2019.0
Cholinergic agents: 2-oxazolidinone analogues of the acetylcholine-receptor muscarinic agonist pilocarpine
Bioorganic &amp; Medicinal Chemistry Letters 1991.0
Rational Design of Partial Agonists for the Muscarinic M<sub>1</sub>Acetylcholine Receptor
Journal of Medicinal Chemistry 2015.0